Traws Pharma Falls After FDA Puts Flu Drug Application on Clinical Hold

Traws Pharma stock dropped 23% today after the FDA placed a clinical hold on its monthly flu prevention pill due to mutagenicity concerns. Positive COVID drug results couldn’t offset the news.